Casasanta N, Patel R, Raymond S, Kier MW, et al. Correlating Predicted Adjuvant Therapy Benefit and Risk of Recurrence Between Breast Cancer Index (BCI) and the 21-Gene Oncotype DX Recurrence Score (RS). Clin Breast Cancer 2024 Jun 12:S1526-8209(24)00167.
PMID: 38971641